CapsoVision, Inc. (NASDAQ: CV) continued its impressive market performance with a 7.14% surge in after-hours trading on Wednesday. This comes on the heels of the medical technology company's successful initial public offering (IPO) and strong intraday trading debut.

Earlier in the day, CapsoVision saw its shares soar 6.90% during regular trading hours, reflecting robust investor interest in the newly public company. The IPO, priced at $5 per share, aimed to raise approximately $27.5 million in gross proceeds. CapsoVision offered 5.5 million shares to the public, with trading commencing on the Nasdaq under the ticker symbol "CV".

The continued enthusiasm in after-hours trading suggests that investors remain optimistic about CapsoVision's prospects in the medical technology sector. The company's strong market reception, both during its IPO and in subsequent trading, may be driving further interest from investors who see potential for growth in the innovative medical technology space. As CapsoVision settles into its role as a public company, market participants will likely continue to closely monitor its performance and growth trajectory.